These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32334046)

  • 1. Demographics and outcomes of meningioma patients treated at a tertiary care center in the Middle East.
    Assi HI; Hilal L; Abu-Gheida I; Berro J; Sukhon F; Skaf G; Geara F; Boulos F; Charafeddine M; Tabbarah A; Khoury J; Najjar M
    Clin Neurol Neurosurg; 2020 Aug; 195():105846. PubMed ID: 32334046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO grade II and III meningiomas: a study of prognostic factors.
    Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
    J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
    J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
    Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
    World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.
    Balasubramanian SK; Sharma M; Silva D; Karivedu V; Schmitt P; Stevens GH; Barnett GH; Prayson RA; Elson P; Suh JH; Murphy ES; Chao ST
    J Neurooncol; 2017 Feb; 131(3):555-563. PubMed ID: 27864703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
    Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
    World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
    Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
    Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
    J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort.
    Tosefsky K; Rebchuk AD; Wang JZ; Ellenbogen Y; Drexler R; Ricklefs FL; Sauvigny T; Schüller U; Cutler CB; Lucke-Wold B; Mehkri Y; Lama S; Sutherland GR; Karsy M; Hoh BL; Westphal M; Zadeh G; Yip S; Makarenko S
    J Neurosurg; 2024 Feb; 140(2):393-403. PubMed ID: 37877968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histopathological predictors of outcome in malignant meningioma.
    Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
    Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes of 17 patients with atypical spinal meningioma, including 4 with metastases: a retrospective observational study.
    Noh SH; Kim KH; Shin DA; Park JY; Yi S; Kuh SU; Kim KN; Chin DK; Kim KS; Yoon DH; Cho YE
    Spine J; 2019 Feb; 19(2):276-284. PubMed ID: 29906618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
    Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
    Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
    Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
    Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
    Gousias K; Schramm J; Simon M
    J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
    Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
    World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
    Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
    J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.